U.S. soybean sales to China ground to a halt after Beijing threatened tariffs on imports, the CEO of agricultural trader Bunge Ltd said on Wednesday, the latest sign of mounting trade tensions upsetting the global flow of commodities.
Countries such as Brazil and Canada are increasing soybean sales to China following Beijing’s threat last month to impose a 25 percent tariff on imports of U.S. soybeans, Chief Executive Soren Schroder said in an interview. U.S. farmers rely on China as the top buyer of soybeans, but at a current price of about $420 per ton, that translates to a potential tax of more than $100 per ton on shipments.
“Nobody’s willing to take the risk of committing to U.S. soybeans to China in the current context, knowing that there could be a $100 penalty from one day to the other, and no way of managing that risk,” Schroder said after the company reported a quarterly loss.
Soybeans were the United States’ most valuable agricultural export last year to China, which bought $12 billion of the crop.
Freshly harvested South American soybeans typically dominate the world trade in the first half of the calendar year, followed by the United States from September onwards.
But U.S. soybean sales to China over the last four weeks are down 10 percent from this time a year ago, according to U.S. trade figures – a blow to U.S. farm country, which helped propel U.S. President Donald Trump into office in the 2016 election.
Growing trade disputes are disrupting the agricultural supply chain worldwide and causing U.S. farmers and manufacturers to back away from expansion plans due to steel and aluminum tariffs.
“The trade stuff has been another layer of uncertainty that nobody really knows how to price yet,” Schroder said.
Separately, Beijing slapped hefty anti-dumping deposits on U.S. imports of a livestock feed known as sorghum.
Bunge’s rival, Archer Daniels Midland, said on Tuesday it would take a $30-million hit in the second quarter due to the sorghum dispute.
ADM is closely monitoring U.S. trade developments regarding China and the North American Free Trade Agreement, CEO Juan Luciano said.
Bunge has seen trade flows shift amid NAFTA renegotiations as well. In one example, Bunge milled wheat that had been imported to Mexico from Argentina as a test, Schroder said.
Mexican buyers imported ten times more corn from Brazil last year due to concerns that NAFTA renegotiations could disrupt their U.S. supplies.
BUNGE SEES MARGIN IMPROVEMENT
The shift in China’s soybean business is not a net negative for Bunge because it has operations globally, Schroder said.
“If there is a problem in one part of the world, we can solve it in another,” he said.
Bunge reported a net loss of 20 cents per share in the quarter ended March 31, down from a profit of 31 cents a share a year ago. The loss included a $120 million charge due to forward oilseeds crushing contracts, which Bunge said it would recover.
Improved margins for soybean crushing should boost earnings significantly this year, executives said, after a severe drought reduced harvests in Argentina, the world’s top exporter of soy products.
The higher margins prompted Bunge to raise its agribusiness unit’s full-year earnings outlook to a range of $800 million to $1 billion from $550 million to $700 million.
Shares gained 2.3 percent to $73.29.
Bunge’s projection for stronger performance was a turnaround after years of bumper harvests reduced price volatility and margins for the company and its rivals, making it tough to turn a profit on their core business: buying, processing and selling corn, soy and wheat.
A string of weak results over the past year left Bunge’s management fending off takeover approaches from traders Glencore PLC and ADM.
By Tom Polansek
US scientists have reprogrammed E. coli to produce chondroitin sulfate, a polysaccharide molecule used in pharmaceuticals and nutraceuticals.
Flow Alkaline Spring Water has announced the appointment of former Nestlé Waters head, Maurizio Patarnello, to the role of CEO.
Danone has announced that Emmanuel Faber will be stepping down as CEO to focus on his role as non-executive chairman, following pressure to split the functions from investors.